Chargement en cours...
MicroRNA-375 represses tumor angiogenesis and reverses resistance to sorafenib in hepatocarcinoma
Sorafenib was originally identified as an inhibitor of multiple oncogenic kinases and remains the first-line systemic therapy for advanced hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) have been reported to play critical roles in the initiation, progression, and drug resistance of HCC. In this...
Enregistré dans:
| Publié dans: | Cancer Gene Ther |
|---|---|
| Auteurs principaux: | , , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group US
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7886652/ https://ncbi.nlm.nih.gov/pubmed/32616906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41417-020-0191-x |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|